Literature DB >> 22544491

RNAi-mediated blocking of ezrin reduces migration of ectopic endometrial cells in endometriosis.

Qiao-Ying Jiang1, Jian-Mei Xia, Hai-Gang Ding, Xiang-Wei Fei, Jun Lin, Rui-Jin Wu.   

Abstract

Ezrin is a member of the ezrin-radixin-moesin (ERM) family of membrane-cytoskeletal linkage proteins. It is important for maintenance of cell shape, adhesion, migration and division. The overexpression of ezrin in some tumours is associated with increased cell migration that is mediated by the Rho/ROCK family of small GTPases. To investigate the role of ezrin in the migration of ectopic endometrial cells in endometriosis, we conducted real-time quantitative RT-PCR analysis of the eutopic and ectopic endometrium from women with endometriosis compared with those without the disease. RNAi, wound healing assays and western blot analysis of endometriotic cells were also included in this research. We found significantly higher levels of mRNA expression of ezrin (0.42 versus 0.27, P < 0.05), RhoA (0.99 versus 0.74, P < 0.05), RhoC (0.79 versus 0.43, P < 0.005) and ROCK1 (0.68 versus 0.38, P < 0.005) in the ectopic endometrial cells compared with the eutopic endometrial cells in endometriosis. Blocking ezrin with small-interfering RNA reduced the migration of ectopic endometrial cells with decreased expression of RhoA (42.68%), RhoC (58.42%) and ROCK1 (59.88%). Our results indicate that the over-expression of ezrin in endometriosis may play a significant role in the migration of endometrial cells of endometriosis, and the RhoC/Rock pathway may provide a promising treatment target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544491     DOI: 10.1093/molehr/gas019

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  8 in total

1.  Knockdown of ezrin suppresses the migration and angiogenesis of human umbilical vein endothelial cells in vitro.

Authors:  Liang-Ping Zhao; Lei Huang; Xun Tian; Feng-Qi Liang; Jun-Cheng Wei; Xian Zhang; Sha Li; Qing-Hua Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

Review 2.  Ezrin Orchestrates Signal Transduction in Airway Cells.

Authors:  Lei-Miao Yin; Ting-Ting Duan; Luis Ulloa; Yong-Qing Yang
Journal:  Rev Physiol Biochem Pharmacol       Date:  2018       Impact factor: 5.545

Review 3.  Nanoparticles in pregnancy: the next frontier in reproductive therapeutics.

Authors:  Natasha Pritchard; Tu'uhevaha Kaitu'u-Lino; Lynda Harris; Stephen Tong; Natalie Hannan
Journal:  Hum Reprod Update       Date:  2021-02-19       Impact factor: 17.179

4.  Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme.

Authors:  Leroi V DeSouza; Ajay Matta; Zia Karim; Joydeep Mukherjee; X Simon Wang; Olga Krakovska; Gelareh Zadeh; Abhijit Guha; Kw Michael Siu
Journal:  Mol Cancer       Date:  2013-07-15       Impact factor: 27.401

5.  Stem cell differentiation increases membrane-actin adhesion regulating cell blebability, migration and mechanics.

Authors:  Kristina Sliogeryte; Stephen D Thorpe; David A Lee; Lorenzo Botto; Martin M Knight
Journal:  Sci Rep       Date:  2014-12-04       Impact factor: 4.379

6.  RhoA/ROCK pathway mediates the effect of oestrogen on regulating epithelial-mesenchymal transition and proliferation in endometriosis.

Authors:  Zhi-Xiong Huang; Xiao-Mei Mao; Rong-Feng Wu; Shao-Min Huang; Xin-Yu Ding; Qiong-Hua Chen; Qing-Xi Chen
Journal:  J Cell Mol Med       Date:  2020-07-29       Impact factor: 5.310

7.  Dysregulation of miR-202-3p Affects Migration and Invasion of Endometrial Stromal Cells in Endometriosis via Targeting ROCK1.

Authors:  Ming Zhang; Yuanzhen Zhang; Li Li; Ling Ma; Chun Zhou
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

8.  RhoA/ROCK/ARHGAP26 signaling in the eutopic and ectopic endometrium is involved in clinical characteristics of adenomyosis.

Authors:  Caixia Jiang; Wei Gong; Rong Chen; Huihui Ke; Xiaoyan Qu; Weihong Yang; Zhongping Cheng
Journal:  J Int Med Res       Date:  2018-11-02       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.